.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Baxter
Dow
Colorcon
Express Scripts
Federal Trade Commission
McKesson
Merck
Covington

Generated: November 20, 2017

DrugPatentWatch Database Preview

Anacor Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ANACOR PHARMS INC, and when can generic versions of ANACOR PHARMS INC drugs launch?

ANACOR PHARMS INC has two approved drugs.

There are nine US patents protecting ANACOR PHARMS INC drugs.

There are one hundred patent family members on ANACOR PHARMS INC drugs in twenty-two countries.

Summary for Anacor Pharms Inc

International Patents:100
US Patents:9
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anacor Pharms Inc
KERYDIN
tavaborole
SOLUTION;TOPICAL204427-001Jul 7, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Anacor Pharms Inc
KERYDIN
tavaborole
SOLUTION;TOPICAL204427-001Jul 7, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Anacor Pharms Inc
EUCRISA
crisaborole
OINTMENT;TOPICAL207695-001Dec 14, 2016RXYesYes► Subscribe► Subscribe ► Subscribe
Anacor Pharms Inc
KERYDIN
tavaborole
SOLUTION;TOPICAL204427-001Jul 7, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Anacor Pharms Inc
KERYDIN
tavaborole
SOLUTION;TOPICAL204427-001Jul 7, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Anacor Pharms Inc
EUCRISA
crisaborole
OINTMENT;TOPICAL207695-001Dec 14, 2016RXYesYes► Subscribe► Subscribe ► Subscribe
Anacor Pharms Inc
EUCRISA
crisaborole
OINTMENT;TOPICAL207695-001Dec 14, 2016RXYesYes► Subscribe► Subscribe► Subscribe
Anacor Pharms Inc
EUCRISA
crisaborole
OINTMENT;TOPICAL207695-001Dec 14, 2016RXYesYes► Subscribe► Subscribe ► Subscribe
Anacor Pharms Inc
KERYDIN
tavaborole
SOLUTION;TOPICAL204427-001Jul 7, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Anacor Pharms Inc
EUCRISA
crisaborole
OINTMENT;TOPICAL207695-001Dec 14, 2016RXYesYes► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Anacor Pharms Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,029,353Boron-containing small molecules as anti-inflammatory agents► Subscribe
7,767,657Boron-containing small molecules► Subscribe
8,722,917Boron-containing small molecules► Subscribe
8,889,656Boron-containing small molecules► Subscribe
9,353,133Boron-containing small molecules► Subscribe
8,440,642Boron-containing small molecules► Subscribe
8,115,026Boron-containing small molecules► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Anacor Pharms Inc Drugs

Country Document Number Estimated Expiration
China106008583► Subscribe
Denmark2343304► Subscribe
South Korea20130100019► Subscribe
China101420854► Subscribe
BrazilPI0708051► Subscribe
World Intellectual Property Organization (WIPO)2007095638► Subscribe
South Korea101337045► Subscribe
China106008571► Subscribe
South Korea101456815► Subscribe
Japan2013253097► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
Cipla
Harvard Business School
Fish and Richardson
Accenture
McKesson
Daiichi Sankyo
Moodys
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot